| SAREPTA THERAP. DL-,0001 |
| USA |
| Gesundheit |
| US8036071004 / A1J1BH |
| AB3A (Frankfurt) / SRPT (NASDAQ) |
| FRA:AB3A, ETR:AB3A, AB3A:GR, NASDAQ:SRPT |
| - |
| https://www.sarepta.com/ |
|
Sarepta Therapeutics Inc. is a biopharmaceutical c..
>Volltext.. |
| 1756.64 Mio. EUR |
| 2226.11 Mio. EUR |
| 2125.37 Mio. EUR |
| 48.22 Mio. EUR |
| -49.64 Mio. EUR |
| -0.5 EUR |
| 1159.56 Mio. EUR |
| 437.31 Mio. EUR |
| -257.59 Mio. EUR |
| 0.87 |
| 49.93% |
| -211.42% |
| - |
| - |
| - |
| - |
| SAREPTA, AVI BIOPHARMA |
| 19.08.25 |
|